When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.* They just ...

Key presentation unveiled Acuitas’ Next-Generation LNP Advancements, which is designed to enhance potency and safety, expand delivery beyond the liver, and enable broader therapeutic impact Additional ...

CHARLOTTETOWN, Prince Edward Island & VANCOUVER, British Columbia--(BUSINESS WIRE)--BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service ...

Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE CVAC, accusing it of failing to credit Acuitas on patents related to COVID-19 ...

Expands Pfizer’s access to lipid nanoparticle (LNP) formulation technology, offering a strong strategic fit with Pfizer’s mRNA strategy Pfizer gains option to license Acuitas’ LNP technology for up to ...

Acuitas’ LNP enabled delivery of three doses of a personalized CRISPR therapy with no adverse events to an infant patient with severe urea cycle disorder Athebody® DARPin-conjugated LNP resulted in ...

(Reuters) -The biotech company that makes mRNA-delivery technology for Pfizer's COVID-19 vaccine sued Arbutus Biopharma Corp in Manhattan federal court on Friday, seeking to head off claims that the ...

Following Justin Trudeau’s decision to invoke emergency powers in an effort to end ongoing trucker demonstrations, rumors surfaced insinuating a link between the Canadian prime minister’s family ...

Collaboration expands Aldevron’s capabilities in mRNA lipid nanoparticle encapsulation FARGO, N.D. & VANCOUVER, British Columbia, May 13, 2024--(BUSINESS WIRE)--Aldevron, a leading global manufacturer ...

VANCOUVER, British Columbia, May 16, 2025--(BUSINESS WIRE)--Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems for the acceleration of partners’ clinical development, ...

Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies “We are thrilled ...